Susanne Stuffers
Chief Executive Officer bei P53 Invest AS
Vermögen: 12 587 $ am 31.03.2024
Profil
Susanne Stuffers is currently the Chief Executive Officer & Managing Partner and CEO & Founding Partner at P53 Invest AS and P53 respectively.
She is also the Vice Chairman at Arxx Therapeutics AS.
Previously, she worked as a Director at Nykode Therapeutics ASA, Independent Director at Gentian Diagnostics ASA, and Director at EXACT Therapeutics AS.
She was also a Lead Analyst at Arctic Securities AS from 2015 to 2018.
Dr. Stuffers holds a doctorate degree from Erasmus University Rotterdam, which she received in 2003.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENTIAN DIAGNOSTICS ASA
0,02% | 31.12.2022 | 3 500 ( 0,02% ) | 12 587 $ | 31.03.2024 |
Aktive Positionen von Susanne Stuffers
| Unternehmen | Position | Beginn |
|---|---|---|
P53 Invest AS
 P53 Invest AS Financial ConglomeratesFinance Part of T.D. Veen AS, P53 Invest AS provides investment services for the healthcare industry. The private company is based in Oslo, Norway. Susanne Stuffers has been the CEO of the Norwegian company since 2018. | Chief Executive Officer | 01.11.2018 |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Director/Board Member | - |
Ehemalige bekannte Positionen von Susanne Stuffers
| Unternehmen | Position | Ende |
|---|---|---|
Arctic Securities AS
 Arctic Securities AS Investment Banks/BrokersFinance Arctic Securities AS is a Norwegian company that provides brokerage services. The private company is based in Oslo, Norway. and has subsidiaries in Norway, Sweden and Germany. The company was founded in 2007 by Jon G. Pedersen, Mads Henrik Syversen. Mads Henrik Syversen has been the CEO since 2007. | Analyst-Equity | 01.10.2018 |
| EXACT THERAPEUTICS | Director/Board Member | - |
| GENTIAN DIAGNOSTICS | Director/Board Member | - |
| NYKODE THERAPEUTICS | Director/Board Member | - |
Ausbildung von Susanne Stuffers
| Erasmus University Rotterdam | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NYKODE THERAPEUTICS | Health Technology |
| GENTIAN DIAGNOSTICS | Health Technology |
| EXACT THERAPEUTICS | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Arctic Securities AS
Arctic Securities AS Investment Banks/BrokersFinance Arctic Securities AS is a Norwegian company that provides brokerage services. The private company is based in Oslo, Norway. and has subsidiaries in Norway, Sweden and Germany. The company was founded in 2007 by Jon G. Pedersen, Mads Henrik Syversen. Mads Henrik Syversen has been the CEO since 2007. | Finance |
P53 Invest AS
P53 Invest AS Financial ConglomeratesFinance Part of T.D. Veen AS, P53 Invest AS provides investment services for the healthcare industry. The private company is based in Oslo, Norway. Susanne Stuffers has been the CEO of the Norwegian company since 2018. | Finance |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Health Technology |
